Ischemic nephropathy: More than a simple renal artery narrowing

Iranian Journal of Kidney Diseases

Volumn 7, Issue 2, 2013, Pages 82-100

  Khatami, Mohammad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Renal artery obstruction; Renovascular hypertension; Revascularization

Indexed keywords

ADENOSINE; ANGIOTENSIN; ANGIOTENSIN II; CELL PROTEIN; COLLAGEN TYPE 4; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; GROWTH FACTOR; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NORADRENALIN; NUCLEAR FACTOR KAPPA LIGHT CHAIN ENHANCER; PLATELET DERIVED GROWTH FACTOR BETA; REACTIVE OXYGEN METABOLITE; TISSUE GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOPLASTY; ARTERIAL STENT; ATHEROSCLEROTIC KIDNEY ARTERY STENOSIS; ATROPHY; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY ATROPHY; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY SCINTISCANNING; KIDNEY SIZE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PROTEINURIA; REPERFUSION INJURY; RESTENOSIS; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURVIVAL RATE; ULTRASOUND;

AGED; ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; ISCHEMIA; KIDNEY; KIDNEY DISEASES; MALE; RENAL ARTERY; RENAL ARTERY OBSTRUCTION;

EID: 84875178300     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet. 1993;341:415-418.
2. Mailloux LU, Bellucci AG, Mossey RT, et al. Predictors of survival in patients undergoing dialysis. Am J Med. 1988;84:855-862.
3. Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol. 1989;31:119-122.
4. Appel RG, Bleyer AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 1995;48:171-176.
5. Piccoli G, Salomone M, Quarello F, et al. Regional registry of dialysis and transplantation of Piedmont, Italy (RPDT). Thirteen years of experience. Regional Registry of Dialysis and Transplantation. Nephrol Dial Transplant. 1995;10:444-447.
6. Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens. 1997;15:1365-1377.
7. Zucchelli P, Zuccala A. Ischemic nephropathy. J Nephrol. 1999;12 Suppl 2:S152-S160.
8. Textor SC. Ischemic nephropathy: where are we now? J Am Soc Nephrol. 2004;15:1974-1982.
9. Jacobson HR. Ischemic renal disease: an overlooked clinical entity? Kidney Int. 1988;34:729-743.
10. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443-451.
11. Textor SC, McKusick MA. Renovascular hypertension and ischemic nephropathy: angioplasty and stenting. In: Brady HR, Wilcox CS, editors. Therapy in nephrology and hypertension. Philadelphia, PA: WB Saunders; 2003. p. 599-609.
12. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293-301.
13. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N-51N.
14. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001;12:2753-8.
15. Schwartz CJ, White TA. STENOSIS OF RENAL ARTERY: AN UNSELECTED NECROPSY STUDY. Br Med J. 1964;2:1415-1421.
16. Holley KE, Hunt JC, Brown AL, Jr., Kincaid OW, Sheps SG. RENAL ARTERY STENOSIS. A CLINICAL- PATHOLOGIC STUDY IN NORMOTENSIVE AND HYPERTENSIVE PATIENTS. Am J Med. 1964;37:14-22.
17. Sawicki PT, Kaiser S, Heinemann L, Frenzel H, Berger M. Prevalence of renal artery stenosis in diabetes mellitus-- an autopsy study. J Intern Med. 1991;229:489-492.
18. Kuroda S, Nishida N, Uzu T, et al. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke. 2000;31:61-65.
19. Louie J, Isaacson JA, Zierler RE, Bergelin RO, Strandness DE, Jr. Prevalence of carotid and lower extremity arterial disease in patients with renal artery stenosis. Am J Hypertens. 1994;7:436-439.
20. Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med. 1998;129:705-711.
21. Alcazar JM, Marin R, Gomez-Campdera F, Orte L, Rodriguez-Jornet A, Mora-Macia J. Clinical characteristics of ischaemic renal disease. Nephrol Dial Transplant. 2001;16 Suppl 1:74-77.
22. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 1998;352:13-16.
23. Buller CE, Nogareda JG, Ramanathan K, et al. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol. 2004;43:1606-1613.
24. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis. 1994;24:622-629.
25. Connolly JO, Higgins RM, Walters HL, et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. QJM. 1994;87:413-421.
26. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309-316.
27. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin Nephrol. 1996;16:2-11.
28. Gosset J, Olin JW. Atherosclerotic renovascular disease: clinical clues and natural history. J Endovasc Surg. 1997;4:316-320.
29. Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608-1616.
30. Ramirez G, Bugni W, Farber SM, Curry AJ. Incidence of renal artery stenosis in a population having cardiac catheterization. South Med J. 1987;80:734-737.
31. Zoccali C, Mallamaci F, Finocchiaro P. Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J Am Soc Nephrol. 2002;13 Suppl 3:S179-S183.
32. Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med. 1994;96:10-14.
33. Iglesias JI, Hamburger RJ, Feldman L, Kaufman JS. The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease. Am J Med. 2000;109:642-647.
34. de Silva R, Loh H, Rigby AS, et al. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. Am J Cardiol. 2007;100:273-279.
35. MacDowall P, Kalra PA, O'Donoghue DJ, et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 1998;352:13-16.
36. Pickering TG, Herman L, Devereux RB, et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet. 1988;2:551-552.
37. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001;37:1184-1190.
38. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712-719.
39. Scoble JE, Hamilton G. Atherosclerotic renovascular disease. BMJ. 1990;300:1670-1671.
40. van Ampting JM, Penne EL, Beek FJ, Koomans HA, Boer WH, Beutler JJ. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant. 2003;18:1147-1151.
41. Herrera AH, Davidson RA. Renovascular disease in older adults. Clin Geriatr Med. 1998;14:237-254.
42. Valderrabano F, Berthoux FC, Jones EH, Mehls O. Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association- European Renal Association. Nephrol Dial Transplant. 1996;11 Suppl 1:2-21.
43. van Ampting JM, Penne EL, Beek FJ, Koomans HA, Boer WH, Beutler JJ. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant. 2003;18:1147-1151.
44. Coen G, Manni M, Giannoni MF, et al. Ischemic nephropathy in an elderly nephrologic and hypertensive population. Am J Nephrol. 1998;18:221-227.
45. Main J. Atheromatous renal artery stenosis rarely causes renal failure. Nephrol Dial Transplant. 2000;15:924-925.
46. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735-742.
47. Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness DE, Jr. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9:1055-1061.
48. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866-2872.
49. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383-392.
50. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE, Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg. 1994;19:250-257; discussion 7-8.
51. Tollefson DF, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg. 1991;14:327-331.
52. Dean RH, Kieffer RW, Smith BM, et al. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg. 1981;116:1408-1415.
53. Leertouwer TC, Pattynama PM, van den Berg-Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int. 2001;59: 1480-1483.
54. Chabova V, Schirger A, Stanson AW, McKusick MA, Textor SC. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc. 2000;75:437-444.
55. Suresh M, Laboi P, Mamtora H, Kalra PA. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant. 2000;15:631-636.
56. Kennedy DJ, Colyer WR, Brewster PS, et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis. 2003;42:926-935.
57. Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9:252-256.
58. Textor SC. Renovascular hypertension and ischemic nephropathy. In: Brenner BM, Rector FC, editors. The kidney. Philadelphia, PA: WB Saunders; 2004. p. 2065-2108.
59. Textor SC. Renovascular hypertension. Endocrinol Metab Clin North Am. 1994;23:235-253.
60. Chabova V, Schirger A, Stanson AW, McKusick MA, Textor SC. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc. 2000;75:437-444.
61. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens. 1999;17:1743-1750.
62. Yoshida H, Kon V, Ichikawa I. Polymorphisms of the renin- angiotensin system genes in progressive renal diseases. Kidney Int. 1996;50:732-744.
63. Losito A, Parente B, Cao PG, Jeffery S, Afzal AR. ACE gene polymorphism and survival in atherosclerotic renovascular disease. Am J Kidney Dis. 2000;35:211-215.
64. Cheung CM, Wright JR, Shurrab AE, et al. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol. 2002;13:149-157.
65. Pickering TG, Laragh JH. Renovascular hypertension. In: Brenner BM, Rector FC Jr, editors. The Kidney. 5th ed. Philadelphia, WB Saunders; 1991. p. 1940-1967.
66. Chen R, Novick AC, Pohl M. Reversible renin mediated massive proteinuria successfully treated by nephrectomy. J Urol. 1995;153:133-134.
67. Greco BA, Breyer JA. Atherosclerotic ischemic renal disease. Am J Kidney Dis. 1997;29:167-187.
68. Epstein FH. Oxygen and renal metabolism. Kidney Int. 1997;51:381-385.
69. Textor SC, Wilcox CS. Ischemic nephropathy/azotemic renovascular disease. Semin Nephrol. 2000;20:489-502.
70. Imanishi M, Akabane S, Takamiya M, et al. Critical degree of renal arterial stenosis that causes hypertension in dogs. Angiology. 1992;43:833-842.
71. Farmer CK, Cook GJ, Blake GM, Reidy J, Scoble JE. Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis. Nephrol Dial Transplant. 1999;14:2880-2884.
72. Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med. 2001;52:421-442.
73. Novick AC. Patient selection for intervention to preserve renal function in ischemic renal disease. In: Novick AC, Scoble J, Hamilton G, editors. Renal vascular disease. London: HBJ College & School Division; 1996. p. 323-337.
74. Textor SC, Novick AC, Tarazi RC, Klimas V, Vidt DG, Pohl M. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med. 1985;102:308-314.
75. Lerman LO, Nath KA, Rodriguez-Porcel M, et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37:541-6.
76. Chade AR, Rodriguez-Porcel M, Grande JP, et al. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol. 2003;23:1295-1301.
77. Textor SC, Novick AC, Steinmuller DR, Streem SB. Renal failure limiting antihypertensive therapy as an indication for renal revascularization. A case report. Arch Intern Med. 1983;143:2208-2211.
78. Gross CM, Kramer J, Weingartner O, et al. Determination of renal arterial stenosis severity: comparison of pressure gradient and vessel diameter. Radiology. 2001;220:751-756.
79. Chade AR, Rodriguez-Porcel M, Grande J P, et al. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation. 2002;106:1165-1171.
80. Stulak JM, Lerman A, Porcel MR, et al. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol. 2001;12:1882-1891.
81. Zhu XY, Chade AR, Rodriguez-Porcel M, et al. Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler Thromb Vasc Biol. 2004;24:1854-1859.
82. Ha H, Endou H. Lipid peroxidation in isolated rat nephron segments. Am J Physiol. 1992;263:F201-F207.
83. Welch WJ, Mendonca M, Aslam S, Wilcox CS. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension. 2003;41:692-696.
84. Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension. 2005;46:943-947.
85. Chade AR, Rodriguez-Porcel M, Herrmann J, et al. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension. 2003;42:605-612.
86. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol. 2002;282:R335-R342.
87. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-beta impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol. 2005;288:F1069-F1077.
88. Zhang H, Akman HO, Smith EL, Zhao J, Murphy-Ullrich JE, Batuman OA. Cellular response to hypoxia involves signaling via Smad proteins. Blood. 2003;101:2253-2260.
89. Roelofs JJ, Rouschop KM, Leemans JC, et al. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol. 2006;17:131-140.
90. Halimi JM, Al-Najjar A, Buchler M, et al. Transplant renal artery stenosis: potential role of ischemia/reperfusion injury and long-term outcome following angioplasty. J Urol. 1999;161:28-32.
91. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17:1503-1520.
92. Sandner P, Hofbauer KH, Tinel H, et al. Expression of adrenomedullin in hypoxic and ischemic rat kidneys and human kidneys with arterial stenosis. Am J Physiol Regul Integr Comp Physiol. 2004;286:R942-R951.
93. Rosenberger C, Mandriota S, Jurgensen JS, et al. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol. 2002;13:1721-1732.
94. Matsumoto M, Tanaka T, Yamamoto T, et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol. 2004;15:1574-1581.
95. Rehling M, Moller ML, Lund JO, Jensen KB, Thamdrup B, Trap-Jensen J. 99mTc-DTPA gamma-camera renography: normal values and rapid determination of single-kidney glomerular filtration rate. Eur J Nucl Med. 1985;11:1-6.
96. Makanjuola AD, Suresh M, Laboi P, Kalra PA, Scoble JE. Proteinuria in atherosclerotic renovascular disease. QJM. 1999;92:515-518.
97. Wright JR, Shurrab AE, Cheung C, et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis. 2002;39:1153-1161.
98. Zalunardo N, Tuttle KR. Atherosclerotic renal artery stenosis: current status and future directions. Curr Opin Nephrol Hypertens. 2004;13:613-621.
99. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
100. Khosla S, Kunjummen B, Manda R, et al. Prevalence of renal artery stenosis requiring revascularization in patients initially referred for coronary angiography. Catheter Cardiovasc Interv. 2003;58:400-403.
101. Plouin PF. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis. 2003;42:851-857.
102. White CJ. Open renal arteries are better than closed renal arteries. Cathet Cardiovasc Diagn. 1998;45:9-10.
103. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
104. Spies KP, Fobbe F, El-Bedewi M, Wolf KJ, Distler A, Schulte KL. Color-coded duplex sonography for noninvasive diagnosis and grading of renal artery stenosis. Am J Hypertens. 1995;8:1222-1231.
105. Williams GJ, Macaskill P, Chan SF, et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol. 2007;188:798-811.
106. Ikee R, Kobayashi S, Hemmi N, et al. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis. 2005;46:603-609.
107. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410-417.
108. Pedersen EB. New tools in diagnosing renal artery stenosis. Kidney Int. 2000;57:2657-2677.
109. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-682; discussion 82.
110. Schoenberg SO, Rieger J, Nittka M, Dietrich O, Johannson LO, Reiser MF. Renal MR angiography: current debates and developments in imaging of renal artery stenosis. Semin Ultrasound CT MR. 2003;24:255-267.
111. Postma CT, Joosten FB, Rosenbusch G, Thien T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J Hypertens. 1997;10:957-963.
112. Tan KT, van Beek EJ, Brown PW, van Delden OM, Tijssen J, Ramsay LE. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol. 2002;57:617-624.
113. Leung DA, Hoffmann U, Pfammatter T, et al. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease. Hypertension. 1999;33:726-731.
114. De Cobelli F, Venturini M, Vanzulli A, et al. Renal arterial stenosis: prospective comparison of color Doppler US and breath-hold, three-dimensional, dynamic, gadolinium- enhanced MR angiography. Radiology. 2000;214:373-380.
115. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135:401-411.
116. Setaro JF, Saddler MC, Chen CC, et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension. 1991;18:289-298.
117. Pedersen EB. Angiotensin-converting enzyme inhibitor renography. Pathophysiological, diagnostic and therapeutic aspects in renal artery stenosis. Nephrol Dial Transplant. 1994;9:482-492.
118. Setaro JF, Chen CC, Hoffer PB, Black HR. Captopril renography in the diagnosis of renal artery stenosis and the prediction of improvement with revascularization. The Yale Vascular Center experience. Am J Hypertens. 1991;4:698S-705S.
119. Fommei E, Mezzasalma L, Ghione S, et al. European Captopril Radionuclide Test Multicenter Study. Preliminary results. Inspective renographic analysis. The European Captopril Radionuclide Test Multicenter Study Group. Am J Hypertens. 1991;4:690S-697S.
120. McLean AG, Hilson AJ, Scoble JE, et al. Screening for renovascular disease with captopril-enhanced renography. Nephrol Dial Transplant. 1992;7:211-215.
121. Haller C. Arteriosclerotic renal artery stenosis: conservative versus interventional management. Heart. 2002;88:193-197.
122. Chonchol M, Linas S: Renal artery stenosis. Primary Care Case Reviews. 2002;5:167-173.
123. Hollenberg NK. Treatment of hypertension: the place of angiotensin-converting enzyme inhibitors in the nineties. J Cardiovasc Pharmacol. 1992;20 Suppl 10:S29-S32.
124. Ram CV. Current concepts in renovascular hypertension. Am J Med Sci. 1992;304:53-71.
125. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001;134:629-636.
126. Losito A, Gaburri M, Errico R, Parente B, Cao PG. Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol. 1999;52:339-343.
127. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-1014.
128. Uzzo RG, Novick AC, Goormastic M, Mascha E, Pohl M. Medical versus surgical management of atherosclerotic renal artery stenosis. Transplant Proc. 2002;34:723-725.
129. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med. 2003;114:44-50.
130. Alcazar JM, Rodicio JL. Ischemic nephropathy: clinical characteristics and treatment. Am J Kidney Dis. 2000;36:883-893.
131. Chatziioannou A, Mourikis D, Agroyannis B, et al. Renal artery stenting for renal insufficiency in solitary kidney in 26 patients. Eur J Vasc Endovasc Surg. 2002;23:49-54.
132. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM. 1999;92:159-167.
133. Christensson A. Renovascular disease and renal insufficiency--diagnosis and treatment. Scand J Urol Nephrol. 1999;33:400-405.
134. Tuttle KR, Raabe RD. Endovascular stents for renal artery revascularization. Curr Opin Nephrol Hypertens. 1998;7:695-701.
135. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
136. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12:329-335.
137. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459-465.
138. Textor SC. Revascularization in atherosclerotic renal artery disease. Kidney Int. 1998;53:799-811.
139. Gill-Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Predictors for clinical success at one year following renal artery stent placement. J Endovasc Ther. 2002;9:495-502.
140. Taylor A, Sheppard D, Macleod MJ, et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol. 1997;52:451-457.
141. Tuttle KR, Chouinard RF, Webber JT, et al. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent. Am J Kidney Dis. 1998;32:611-622.
142. Henry M, Amor M, Henry I, et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg. 1999;6:42-51.
143. Cambria RP, Brewster DC, L'Italien GJ, et al. Renal artery reconstruction for the preservation of renal function. J Vasc Surg. 1996;24:371-380; discussion 80-2.
144. Reilly JM, Rubin BG, Thompson RW, et al. Revascularization of the solitary kidney: a challenging problem in a high risk population. Surgery. 1996;120:732-736; discussion 6-7.
145. Symonides B, Chodakowska J, Januszewicz A, et al. Effects of the correction of renal artery stenosis on blood pressure, renal function and left ventricular morphology. Blood Press. 1999;8:141-150.
146. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282-286.
147. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
148. Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133-1136.
149. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78-85.
150. Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-1962.
151. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150:840-8, W150-W151.
152. The CORAL trial. NCT 00081731 [Accessed 8 June 2012]. Available from: http://www.clinicaltrials.gov.
153. van de Ven PJ, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet. 1995;346:672-674.
154. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
155. Dorros G, Jaff M, Mathiak L, He T. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv. 2002;55:182-188.
156. Mikhail A, Cook GJ, Reidy J, Scoble JE. Progressive renal dysfunction despite successful renal artery angioplasty in a single kidney. Lancet. 1997;349:926.
157. Hallett JW, Jr., Textor SC, Kos PB, et al. Advanced renovascular hypertension and renal insufficiency: trends in medical comorbidity and surgical approach from 1970 to 1993. J Vasc Surg. 1995;21:750-759; discussion 9-60.
158. Korsakas S, Mohaupt MG, Dinkel HP, et al. Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int. 2004;65:251-258.
159. Binkert CA, Hoffman U, Leung DA, Matter HG, Schmidt M, Debatin JF. Characterization of renal artery stenoses based on magnetic resonance renal flow and volume measurements. Kidney Int. 1999;56:1846-1854.
160. Darling RC, 3rd, Kreienberg PB, Chang BB, et al. Outcome of renal artery reconstruction: analysis of 687 procedures. Ann Surg. 1999;230:524-530.